AAAAAA

   
Results: 1-7 |
Results: 7
SUCCESSFUL RESOLUTION OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER COMBINATION THERAPY WITH CIDOFOVIR AND CYTOSINE-ARABINOSIDE
Authors: BLICK G WHITESIDE M GRIEGOR P HOPKINS U GARTON T LAGRAVINESE L
Citation: G. Blick et al., SUCCESSFUL RESOLUTION OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER COMBINATION THERAPY WITH CIDOFOVIR AND CYTOSINE-ARABINOSIDE, Clinical infectious diseases, 26(1), 1998, pp. 191-192
PASSIVE IMMUNOTHERAPY IN ADVANCED HIV-INFECTION AND THERAPEUTIC PLASMAPHERESIS IN ASYMPTOMATIC HIV-POSITIVE INDIVIDUALS - A 4-YEAR CLINICAL-EXPERIENCE
Authors: BLICK G SCOTT WF CROOK SW BUCHANAN S GARTON T HOPKINS U VADABONCOEUR AM DOOLITTLE J BULCRAIG IA GREIGERZANLUNGO P KARPAS A
Citation: G. Blick et al., PASSIVE IMMUNOTHERAPY IN ADVANCED HIV-INFECTION AND THERAPEUTIC PLASMAPHERESIS IN ASYMPTOMATIC HIV-POSITIVE INDIVIDUALS - A 4-YEAR CLINICAL-EXPERIENCE, Biotherapy, 11(1), 1998, pp. 7-14
SUCCESSFUL USE OF CIDOFOVIR IN TREATING AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, ENCEPHALITIS, AND ESOPHAGITIS
Authors: BLICK G GARTON T HOPKINS U LAGRAVINESE L
Citation: G. Blick et al., SUCCESSFUL USE OF CIDOFOVIR IN TREATING AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, ENCEPHALITIS, AND ESOPHAGITIS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 84-85
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/, Journal of acquired immune deficiency syndromes and human retrovirology, 11(3), 1996, pp. 315-315
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 279-288
THE 1968-MAY-23 INANGAHUA, NEW-ZEALAND, EARTHQUAKE - AN INTEGRATED GEOLOGICAL, GEODETIC, AND SEISMOLOGICAL SOURCE MODEL - COMMENT - REPLY
Authors: BEANLAND S HAINES J DARBY D ANDERSON H BLICK G DOWNES G JACKSON J ROBINSON R WEBB T
Citation: S. Beanland et al., THE 1968-MAY-23 INANGAHUA, NEW-ZEALAND, EARTHQUAKE - AN INTEGRATED GEOLOGICAL, GEODETIC, AND SEISMOLOGICAL SOURCE MODEL - COMMENT - REPLY, New Zealand Journal of Geology and Geophysics, 37(4), 1994, pp. 500-501
THE 1968 MAY 23 INANGAHUA, NEW-ZEALAND, EARTHQUAKE - AN INTEGRATED GEOLOGICAL, GEODETIC, AND SEISMOLOGICAL SOURCE MODEL
Authors: ANDERSON H BEANLAND S BLICK G DARBY D DOWNES G HAINES J JACKSON J ROBINSON R WEBB T
Citation: H. Anderson et al., THE 1968 MAY 23 INANGAHUA, NEW-ZEALAND, EARTHQUAKE - AN INTEGRATED GEOLOGICAL, GEODETIC, AND SEISMOLOGICAL SOURCE MODEL, New Zealand Journal of Geology and Geophysics, 37(1), 1994, pp. 59-86
Risultati: 1-7 |